(Q46701214)

24 December 2017

title

Combination of photodynamic therapy and immunomodulation for skin diseases--update of clinical aspects (English)

1 reference

24 December 2017

author name string

Xiu-Li Wang

1

1 reference

24 December 2017

Hong-Wei Wang

2

1 reference

24 December 2017

Kai-Hua Yuan

3

1 reference

24 December 2017

Fu-Lun Li

4

1 reference

24 December 2017

Zheng Huang

5

1 reference

24 December 2017

publication date

18 February 2011

1 reference

24 December 2017

Photochemical and Photobiological Sciences

published in

1 reference

24 December 2017

volume

10

1 reference

24 December 2017

issue

5

1 reference

24 December 2017

page(s)

704-711

1 reference

24 December 2017

Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Photodynamic therapy for treatment of solid tumors--potential and technical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

A review of progress in clinical photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Vascular and cellular targeting for photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Photodynamic therapy in treatment of port wine stain birthmarks--recent progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

The effect of Tookad-mediated photodynamic ablation of the prostate gland on adjacent tissues--in vivo study in a canine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Treatment of skin cancer and pre-cancer using topical ALA-PDT--a single hospital experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Actinic cheilitis treated with one cycle of 5-aminolaevulinic acid-based photodynamic therapy: report of 10 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Optimized photodynamic therapy with systemic photosensitizer following debulking technique for nonmelanoma skin cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Photodynamic therapy using a methyl ester of 5-aminolevulinic acid in recurrent Paget's disease of the vulva: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Treatment of perianal Paget's disease using photodynamic therapy with assistance of fluorescence examination: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Topical photodynamic therapy of actinic keratosis in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Topical ALA PDT for the treatment of severe acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Photodynamic therapy as an alternative treatment for cutaneous sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Photodynamic therapy for granuloma annulare: more than a shot in the dark

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Topical 5-aminolaevulinic acid-photodynamic therapy for the treatment of urethral condylomata acuminata

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Comparative study of photodynamic therapy vs CO2 laser vaporization in treatment of condylomata acuminata: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Study of protoporphyrin IX (PpIX) pharmacokinetics after topical application of 5-aminolevulinic acid in urethral condylomata acuminata.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Photosensitized inactivation of microorganisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Photodynamic therapy for localized infections--state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Antifungal photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Photodynamic therapy for infected leg ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Photodynamic therapy-a promising treatment option for autoimmune skin ulcers: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Photodynamic therapy: a useful adjunct therapy for recalcitrant ulceration in pemphigus vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Treatment of cutaneous leishmaniasis with photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Parasiticidal effect of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Photochemotherapy of hypervascular dermal lesions: a possible alternative to photothermal therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Photodynamic therapy of port wine stains-a report of 238 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Comparison of photodynamic therapy and pulsed dye laser in patients with port wine stain birthmarks: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Photodynamic therapy and anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Photodynamic therapy and anti-tumour immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

The influence of photodynamic therapy on the immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Combination of photodynamic therapy and immunomodulation: current status and future trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Topical immunomodulation in dermatology: potential of toll-like receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Photodynamic therapy and imiquimod immunotherapy for basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Sequential treatment of giant basal cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Successful topical immunotherapy of bowenoid papulosis with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Bowenoid papulosis of the vulva—immunotherapeutical approach with topical imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Combination of immunotherapy and photodynamic therapy in the treatment of Bowenoid papulosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Recurrence of port-wine stains after treatment with the flashlamp-pumped pulsed dye laser

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Redarkening of port-wine stains 10 years after pulsed-dye-laser treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Can the wound healing response of human skin be modulated after laser treatment and the effects of exposure extended? Implications on the combined use of the pulsed dye laser and a topical angiogenesis inhibitor for treatment of port wine stain birt

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Pilot study examining the combined use of pulsed dye laser and topical Imiquimod versus laser alone for treatment of port wine stain birthmarks

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

Acute phase response induction by cancer treatment with photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

In situ photoimmunotherapy: a tumour-directed treatment for melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0PP00373E

21 January 2018

Identifiers

DOI

10.1039/C0PP00373E

1 reference

24 December 2017

1 reference

24 December 2017